AwardedSpainGoodsFramework agreement
CBAM 1100/2025 SUMINISTRO DE VACUNA ANTINEUMOCÓCICA CONJUGADA 20-VALENTE Y VACUNA, CON LA MERCANTIL GLAXOSMITHKLINE, CCA: +6.CN1NKHW, CONTR 2026 245404
- Published
- Published 6 July 2026
Overview
The Andalusian Health Service (Servicio Andaluz de Salud) awarded a framework agreement to GlaxoSmithKline, S.A. on 1 July 2026 for the supply of 20-valent pneumococcal conjugate vaccine and meningococcal B vaccine for Andalusia's vaccination programme, valued at EUR 3,670,820. The contract establishes conditions for successive supply and unit pricing of these vaccines.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Procedure
- Direct
- Contract type
- Framework agreement
- Published
- 6 July 2026
Vaccines
Award outcome
- Awarded value
- €3,670,820
- Award date
- 1 July 2026
- Contract period
- 1 July 2026 → 30 June 2028
- GLAXOSMITHKLINE, S.A.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
6 July 2026
Contracting authority
Servicio Andaluz de Salud. Hospital Universitario Puerta del Mar
Procuring entityCádiz, Spain
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.